Protagonist Therapeutics Inc sell StockNews.com
Start price
30.09.23
/
50%
€84.50
Target price
30.09.24
-
Performance (%)
-
End price
01.10.24
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Protagonist Therapeutics Inc | -5.587% | -5.587% | 130.874% |
| iShares Core DAX® | 2.554% | -0.112% | 14.995% |
| iShares Nasdaq 100 | 2.742% | -0.470% | 30.954% |
| iShares Nikkei 225® | 6.584% | 3.221% | 49.697% |
| iShares S&P 500 | 1.930% | -0.519% | 24.883% |
Comments by StockNews_com for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
In the thread Trading Protagonist Therapeutics Inc
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Current prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€41.80
31.05.25
31.05.25
-
31.05.26
31.05.26
102.15%
10.04.26
10.04.26
Stopped prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€84.50
18.10.23
18.10.23
-
18.10.24
18.10.24
-
19.10.24
19.10.24